Table 3.
mRNA | Ensemble ID | Location | B (Cox) | HR (95%CI) | P-value |
---|---|---|---|---|---|
ADA | ENST00000372874.8 | Chr 20: 44,619,522–44,652,233 | 0.167 | 1.182 (0.108–1.550) | P<0.0001 |
FEN1 | ENST00000305885.2 | Chr 11: 61,792,637–61,797,244 | −0.276 | 0.759 (0.149–1.850) | P<0.0001 |
POLR2G | ENST00000301788.11 | Chr 11: 62,761,544–62,766,710 | −0.414 | 0.661 (0.236–1.760) | P<0.0001 |
SAC3D1 | ENST00000398846.5 | Chr 11: 65,040,901–65,044,828 | 0.540 | 1.717 (0.179–3.0 0) | P<0.0001 |
SEC61A1 | ENST00000243253.7 | Chr 3: 128,051,641–128,071,683 | 0.254 | 1.290 (0.175–1.450) | P<0.0001 |
SF3A3 | ENST00000373019.4 | Chr 1: 37,956,975–37,990,921 | 0.667 | 1.949 (0.217–3.070) | P<0.0001 |
UPF3B | ENST00000276201.6 | Chr X: 119,805,311–119,852,998 | 0.233 | 1.263 (0.138–1.690) | P<0.0001 |
Abbreviations: OS, overall survival; HCC, hepatocellular carcinoma; HR, hazard ratio; CI, confidence interval.